HK1086255A1 - Process for preparing 5-[(r)-2-(5,6-diethyl-indan- 2-ylamino)-1hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salts, useful as adrenoceptor agonists - Google Patents
Process for preparing 5-[(r)-2-(5,6-diethyl-indan- 2-ylamino)-1hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salts, useful as adrenoceptor agonistsInfo
- Publication number
- HK1086255A1 HK1086255A1 HK06105984.1A HK06105984A HK1086255A1 HK 1086255 A1 HK1086255 A1 HK 1086255A1 HK 06105984 A HK06105984 A HK 06105984A HK 1086255 A1 HK1086255 A1 HK 1086255A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- 1hydroxy
- indan
- quinolin
- ylamino
- diethyl
- Prior art date
Links
- 108060003345 Adrenergic Receptor Proteins 0.000 title 1
- 102000017910 Adrenergic receptor Human genes 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- QZZUEBNBZAPZLX-QFIPXVFZSA-N indacaterol Chemical class N1C(=O)C=CC2=C1C(O)=CC=C2[C@@H](O)CNC1CC(C=C(C(=C2)CC)CC)=C2C1 QZZUEBNBZAPZLX-QFIPXVFZSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45094503P | 2003-02-28 | 2003-02-28 | |
| PCT/EP2004/001981 WO2004076422A1 (en) | 2003-02-28 | 2004-02-27 | Process for preparing 5-‘(r)-2-(5,6-diethyl-indian-2-ylamino)-1-hydroxy-ethyl!-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1086255A1 true HK1086255A1 (en) | 2006-09-15 |
Family
ID=32927689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06105984.1A HK1086255A1 (en) | 2003-02-28 | 2006-05-24 | Process for preparing 5-[(r)-2-(5,6-diethyl-indan- 2-ylamino)-1hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salts, useful as adrenoceptor agonists |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7534890B2 (en) |
| EP (1) | EP1599450B1 (en) |
| JP (1) | JP4802089B2 (en) |
| KR (1) | KR101076929B1 (en) |
| CN (1) | CN100363349C (en) |
| AR (1) | AR043406A1 (en) |
| AT (1) | ATE434609T1 (en) |
| AU (1) | AU2004215647B2 (en) |
| BR (1) | BRPI0407904B1 (en) |
| CA (1) | CA2517033C (en) |
| CL (1) | CL2004000381A1 (en) |
| CY (1) | CY1109442T1 (en) |
| DE (1) | DE602004021675D1 (en) |
| DK (1) | DK1599450T3 (en) |
| EC (1) | ECSP055977A (en) |
| ES (1) | ES2326974T3 (en) |
| HK (1) | HK1086255A1 (en) |
| IL (1) | IL170138A (en) |
| MX (1) | MXPA05009156A (en) |
| MY (1) | MY142491A (en) |
| NO (1) | NO331985B1 (en) |
| NZ (1) | NZ541727A (en) |
| PE (1) | PE20040956A1 (en) |
| PL (1) | PL213932B1 (en) |
| PT (1) | PT1599450E (en) |
| RU (1) | RU2332405C2 (en) |
| SI (1) | SI1599450T1 (en) |
| TW (1) | TWI324150B (en) |
| WO (1) | WO2004076422A1 (en) |
| ZA (1) | ZA200506060B (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20100399A1 (en) * | 2003-04-02 | 2010-06-01 | Novartis Ag | PROCEDURE TO PREPARE OXY- (1H) -QUINOLIN-2-ONAS 5- (ALPHA-HALOACETIL) -8-SUBSTITUTED |
| JP4516064B2 (en) * | 2003-04-04 | 2010-08-04 | ノバルティス アーゲー | Quinolin-2-one derivatives for the treatment of airway diseases |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| GB0413960D0 (en) * | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
| PL2044025T3 (en) | 2006-06-30 | 2013-02-28 | Novartis Ag | Quinolinone derivatives and their pharmaceutical compositions |
| JP2010520188A (en) | 2007-02-28 | 2010-06-10 | シプラ・リミテッド | Method for preparing carmoterol isomers |
| US8877930B2 (en) | 2009-11-04 | 2014-11-04 | Massachusetts Institute Of Technology | Continuous flow synthesis of amino alcohols using microreactors |
| WO2011109276A1 (en) | 2010-03-01 | 2011-09-09 | Massachussets Institute Of Technology | Epoxidation catalysts |
| WO2013132514A2 (en) * | 2012-03-09 | 2013-09-12 | Rao Davuluri Ramamohan | A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one |
| WO2014008640A1 (en) * | 2012-07-11 | 2014-01-16 | 上海威智医药科技有限公司 | Indacaterol intermediate and method for synthesizing indacaterol |
| WO2014008639A1 (en) * | 2012-07-11 | 2014-01-16 | 上海威智医药科技有限公司 | Method for preparing indacaterol |
| EP3848354B1 (en) | 2012-09-21 | 2022-07-27 | Crystal Pharma, S.A.U. | Process for the preparation of indacaterol and intermediates thereof |
| WO2014044288A1 (en) * | 2012-09-21 | 2014-03-27 | Crystal Pharma Sa | Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof |
| CZ306252B6 (en) * | 2013-03-15 | 2016-10-26 | Zentiva, K.S. | Process for preparing 5-[(R)-2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1H)-quinolin-2-one (indacaterol) |
| EP3205646A3 (en) | 2013-03-27 | 2017-10-04 | Laboratorios Lesvi, S.L. | Intermediates for the manufacture of (r)-5-[2- (5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1h)-quinolin-2-one (indacaterol) |
| ES2815123T3 (en) | 2014-01-09 | 2021-03-29 | Davuluri Ramamohan Rao | Novel process for the preparation of indacaterol or its pharmaceutically acceptable salts |
| US10227305B2 (en) | 2014-08-22 | 2019-03-12 | G. Pratap REDDY | Process for preparing indacaterol and salts thereof |
| CN105693603B (en) * | 2014-11-24 | 2019-11-29 | 上海医药工业研究院 | The maleic acid datro preparation process of improvement |
| WO2016161956A1 (en) * | 2015-04-09 | 2016-10-13 | 正大天晴药业集团股份有限公司 | Preparation method of indacaterol or salt thereof |
| EP3375781A4 (en) * | 2015-07-21 | 2019-01-09 | Sichuan Haisco Pharmaceutical Co., Ltd. | Benzo ring derivative with b2 receptor agonist and m3 receptor antagonist activities and use thereof in medicine |
| EP3347345B1 (en) | 2015-09-29 | 2019-07-31 | Inke, S.A. | Mixed solvate of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1h-quinolin-2-one l-tartrate |
| CN107021921A (en) * | 2016-02-02 | 2017-08-08 | 常州爱诺新睿医药技术有限公司 | A kind of salt of QAB-149 intermediate and preparation method thereof |
| CN107868045A (en) * | 2016-09-28 | 2018-04-03 | 四川海思科制药有限公司 | A kind of preparation method of QAB-149 intermediate |
| CN108101841B (en) * | 2016-11-24 | 2021-04-06 | 江苏恒瑞医药股份有限公司 | Method for preparing indacaterol or salt thereof |
| CN108264483A (en) * | 2016-12-31 | 2018-07-10 | 天津金耀集团有限公司 | A kind of preparation method of maleic acid datro |
| CN109516974B (en) * | 2017-09-19 | 2022-05-27 | 南京圣和药业股份有限公司 | Preparation method of substituted pyrimidine PI3K inhibitor |
| EP3735406B1 (en) | 2018-01-02 | 2022-05-11 | Deva Holding Anonim Sirketi | A process for preparation of 5-(2-(substituted-amino)-1-hydroxyethyl)-8-(substituted-oxy) quinolin-2(1h)-one |
| CN109721534B (en) * | 2018-09-25 | 2022-05-20 | 四川海思科制药有限公司 | Indacaterol maleate intermediate and preparation method and application thereof |
| CN109988111A (en) * | 2019-05-06 | 2019-07-09 | 淮北师范大学 | A kind of impurity and its synthetic method of maleic acid datro |
| CN110128339B (en) * | 2019-05-31 | 2022-03-08 | 苏州芝宇生物科技有限公司 | Synthetic method and intermediate for indacaterol and salt derivative thereof |
| CN113731406B (en) * | 2021-10-12 | 2023-07-28 | 南京工业大学 | Method for improving palladium carbon activity hydrogenation removal protecting group |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9405019D0 (en) | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
-
2004
- 2004-02-25 TW TW093104788A patent/TWI324150B/en not_active IP Right Cessation
- 2004-02-26 PE PE2004000198A patent/PE20040956A1/en not_active Application Discontinuation
- 2004-02-26 AR ARP040100606A patent/AR043406A1/en not_active Application Discontinuation
- 2004-02-27 SI SI200431222T patent/SI1599450T1/en unknown
- 2004-02-27 CA CA2517033A patent/CA2517033C/en not_active Expired - Lifetime
- 2004-02-27 EP EP04715306A patent/EP1599450B1/en not_active Expired - Lifetime
- 2004-02-27 ES ES04715306T patent/ES2326974T3/en not_active Expired - Lifetime
- 2004-02-27 MY MYPI20040645A patent/MY142491A/en unknown
- 2004-02-27 RU RU2005129547/04A patent/RU2332405C2/en active
- 2004-02-27 US US10/546,941 patent/US7534890B2/en active Active
- 2004-02-27 CN CNB2004800054167A patent/CN100363349C/en not_active Expired - Lifetime
- 2004-02-27 MX MXPA05009156A patent/MXPA05009156A/en active IP Right Grant
- 2004-02-27 CL CL200400381A patent/CL2004000381A1/en unknown
- 2004-02-27 DK DK04715306T patent/DK1599450T3/en active
- 2004-02-27 NZ NZ541727A patent/NZ541727A/en not_active IP Right Cessation
- 2004-02-27 DE DE602004021675T patent/DE602004021675D1/en not_active Expired - Lifetime
- 2004-02-27 PT PT04715306T patent/PT1599450E/en unknown
- 2004-02-27 PL PL378358A patent/PL213932B1/en unknown
- 2004-02-27 AU AU2004215647A patent/AU2004215647B2/en not_active Expired
- 2004-02-27 JP JP2006501972A patent/JP4802089B2/en not_active Expired - Lifetime
- 2004-02-27 AT AT04715306T patent/ATE434609T1/en active
- 2004-02-27 WO PCT/EP2004/001981 patent/WO2004076422A1/en active Application Filing
- 2004-02-27 BR BRPI0407904A patent/BRPI0407904B1/en not_active IP Right Cessation
-
2005
- 2005-07-28 ZA ZA200506060A patent/ZA200506060B/en unknown
- 2005-08-07 IL IL170138A patent/IL170138A/en active IP Right Grant
- 2005-08-24 EC EC2005005977A patent/ECSP055977A/en unknown
- 2005-08-26 KR KR1020057015981A patent/KR101076929B1/en active IP Right Grant
- 2005-09-26 NO NO20054452A patent/NO331985B1/en unknown
-
2006
- 2006-05-24 HK HK06105984.1A patent/HK1086255A1/en not_active IP Right Cessation
-
2009
- 2009-09-24 CY CY20091100993T patent/CY1109442T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1086255A1 (en) | Process for preparing 5-[(r)-2-(5,6-diethyl-indan- 2-ylamino)-1hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salts, useful as adrenoceptor agonists | |
| IL175933A (en) | Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt, a pharmaceutical composition comprising the same and a process for preparing the same | |
| IL175139A0 (en) | Phenyl derivatives as ppar agonists | |
| ZA200802453B (en) | Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists | |
| ZA200803926B (en) | 2-(Phenyl or heterocyclic)-1H-phenantrho[9,10-D]imidazoles as MPGES-1 inhibitors | |
| ZA200702382B (en) | Processes for the preparation of substituted 2-(2,6-dioxoplperidin-3-yl)-1-oxoisoindolines | |
| WO2009025983A3 (en) | Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives | |
| HK1073110A1 (en) | Process for preparing aripiprazole | |
| PL378342A1 (en) | 2-piperidone derivatives as prostaglandin agonists | |
| ZA200800542B (en) | 1,4-Dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them | |
| SI1561754T1 (en) | Process for preparing 1,2-Diaminocyclohexane-Platinum(II) complexes | |
| IL172444A0 (en) | Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative | |
| HK1086008A1 (en) | Process for preparing substituted 5-amino-pyrazolo-Ä4,3-eÜ-1,2,4-triazoloÄ1,5-cÜpyrimidines | |
| MA28607B1 (en) | AMINOPYRIDINE DERIVATIVES USEFUL AS SELECTIVE DOPAMINE D3 AGONISTS | |
| HK1144682A1 (en) | Process for the preparation of alkyl 3,3-dialkoxypropionates 33- | |
| IL173445A (en) | 6-(1,1-difluoroalkyl)-4-aminopicolinates for use as herbicides | |
| AP2005003393A0 (en) | 3-(1-Ä3-(1,3-benzothiazol-6-yl) ropylcarbamoylÜcycloalkyl) propanoic acid derivatives as NEP inhibitors. | |
| FR2833561B1 (en) | TOOL HOLDER FOR LINE CROP | |
| IL187673A0 (en) | Process for preparing 3,3-diarylpropylamines | |
| ZA200702070B (en) | Process for preparing substituted 8-azablcyclo[3.2.1] octan-3-ols | |
| FR2854623B1 (en) | AQUO-OXO TITANIUM CHLORIDE, PROCESS FOR PREPARING THE SAME | |
| GB0522075D0 (en) | Process for preparing almodipline mesylate monohydrate | |
| MXPA03009927A (en) | Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists. | |
| ZA200902715B (en) | Process for preparing 5-alkyl-7H-pyrrolo[2,3-d]pyrimidine-2-ols | |
| AU2003259866A8 (en) | Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20240226 |